Healthcare
Orpea S.A.(ORPEF)
Live Price
Offline$14.22
+0.00% today
1Y Change
+0.00%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $1.34B
- Revenue Growth
- +4.6%
- EPS Growth
- +29.4%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Orpea S.A. (ORPEF) is a Healthcare stock with a market cap of $1.34B and listed on OTC. The stock last traded around $14.22 and up 0.0% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +4.6%, EPS growth of +29.4%, a dividend yield of 0.0%. What stands out right now is revenue +4.6%, EPS +29.4%, free cash flow 0.0% with operating margin 2.4% and ROIC 1.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Stock Foundry combines ORPEF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+4.6% vs +7.6% peer median
Operating Margin
Below sector median
+2.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 8, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +4.6% and EPS at +29.4%, with operating margin around 2.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 8, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Sep 30, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Apr 16, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
ORPEF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ORPEF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ORPEF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ORPEF and SPY.
Company Overview
Orpea S.A.
Other OTC
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.
- Leadership
- Laurent Guillot
- IPO Date
- Aug 3, 2012
- Employees
- 51.1k
- Street Address
- 12, rue Jean-JaurEs
- Mailing
- Puteaux, 92813
- Region
- Puteaux, FR
- Reporting Currency
- USD
- Investor Line
- 33 1 47 75 78 07
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 12.0
- Price/Sales
- 0.2
- Price/Book
- 0.9
Growth
- Revenue
- +4.6%
- EPS
- +29.4%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 2.2%
- Operating Margin
- 2.4%
- Net Margin
- -5.1%
- ROE
- -17.7%
- ROIC
- 1.2%
Balance Sheet
- Debt/Equity
- 4.84
- Current Ratio
- 0.59
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.